• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Cardiovascular determinants of survival in cirrhosis.肝硬化患者生存的心血管决定因素
Gut. 2007 Jun;56(6):746-8. doi: 10.1136/gut.2006.112169.
2
Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting.MELD、Child-Pugh和埃默里模型在经颈静脉肝内门体分流术患者生存预测中的比较
Am J Gastroenterol. 2003 May;98(5):1167-74. doi: 10.1111/j.1572-0241.2003.07515.x.
3
Outcomes after transjugular intrahepatic portosystemic stent shunt: a "bridge" to nowhere.经颈静脉肝内门体分流术的转归：一座“没有尽头的桥”。
Am J Surg. 2013 Apr;205(4):441-6. doi: 10.1016/j.amjsurg.2012.06.005. Epub 2013 Jan 30.
4
Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.晚期肝硬化患者经颈静脉肝内门体分流术通过门静脉左支与右支的疗效比较：一项随机试验
Liver Int. 2009 Aug;29(7):1101-9. doi: 10.1111/j.1478-3231.2009.02016.x. Epub 2009 Apr 6.
5
Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus.经颈静脉肝内门体分流术（TIPS）对肝硬化合并糖尿病患者血糖控制的影响。
Am J Gastroenterol. 1998 Mar;93(3):483. doi: 10.1111/j.1572-0241.1998.481_4.x.
6
[Spontaneous bacteremia due to Salmonella hadar in liver cirrhosis with transjugular intrahepatic portosystemic shunt].[肝硬化合并经颈静脉肝内门体分流术患者发生哈达尔沙门氏菌所致自发性菌血症]
Gastroenterol Hepatol. 1999 Feb;22(2):79-81.
7
[Dysfunction of a TIPS (transjugular intrahepatic porto-systemic shunt) and chylous ascites].经颈静脉肝内门体分流术（TIPS）功能障碍与乳糜性腹水
Rev Esp Enferm Dig. 1997 Jun;89(6):475-7.
8
Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study.早期 TIPS 治疗高危静脉曲张出血：一项 RCT 后监测研究的结果。
J Hepatol. 2013 Jan;58(1):45-50. doi: 10.1016/j.jhep.2012.08.020. Epub 2012 Aug 30.
9
The 'Gerstmann's Syndrome' of transjugular intrahepatic portosystemic shunt: should it be the left or should it be the right.经颈静脉肝内门体分流术的“格斯特曼综合征”：应选择左侧还是右侧？
Liver Int. 2009 Sep;29(8):1129-31. doi: 10.1111/j.1478-3231.2009.02094.x.
10
Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.2型肝肾综合征与顽固性腹水：经颈静脉肝内门体分流术在18例等待原位肝移植的晚期肝硬化患者中的作用
Hepatogastroenterology. 2003 Nov-Dec;50(54):1753-5.

引用本文的文献

1
Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis.肝硬化患者经颈静脉肝内门体分流术后的心血管风险评估及心脏失代偿的预测因素
World J Gastroenterol. 2025 Jul 21;31(27):107740. doi: 10.3748/wjg.v31.i27.107740.
2
A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver-heart axis.肝硬化患者左心室舒张功能障碍的病例队列研究：肝-心轴
Ann Gastroenterol. 2023 Nov-Dec;36(6):678-685. doi: 10.20524/aog.2023.0837. Epub 2023 Oct 30.
3
Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.舒张功能障碍是失代偿期肝硬化患者生存预后不良的一个预测指标。
Int J Hepatol. 2021 Dec 2;2021:5592376. doi: 10.1155/2021/5592376. eCollection 2021.
4
In-Hospital Outcomes of Patients with Acute Decompensated Heart Failure and Cirrhosis: An Analysis of the National Inpatient Sample.急性失代偿性心力衰竭合并肝硬化患者的院内结局：一项基于全国住院患者样本的分析
Cardiol Ther. 2020 Dec;9(2):433-445. doi: 10.1007/s40119-020-00183-6. Epub 2020 Jun 8.
5
The Application of the Extended Poincaré Plot in the Analysis of Physiological Variabilities.扩展庞加莱图在生理变异性分析中的应用。
Front Physiol. 2019 Feb 19;10:116. doi: 10.3389/fphys.2019.00116. eCollection 2019.
6
Risk factors for cardiopulmonary and respiratory arrest in medical and surgical hospital patients on opioid analgesics and sedatives.阿片类镇痛药和镇静剂在医、外科住院患者中心肺和呼吸停止的危险因素。
PLoS One. 2018 Mar 22;13(3):e0194553. doi: 10.1371/journal.pone.0194553. eCollection 2018.
7
Role of albumin in cirrhosis: from a hospitalist's perspective.白蛋白在肝硬化中的作用：从一名住院医师的视角
J Community Hosp Intern Med Perspect. 2017 Mar 31;7(1):8-14. doi: 10.1080/20009666.2017.1302704. eCollection 2017 Jan.
8
Predictors of mortality after transjugular portosystemic shunt.经颈静脉肝内门体分流术后死亡的预测因素。
World J Hepatol. 2016 Apr 18;8(11):520-9. doi: 10.4254/wjh.v8.i11.520.
9
Comorbidity in cirrhosis.肝硬化中的共病
World J Gastroenterol. 2014 Jun 21;20(23):7223-30. doi: 10.3748/wjg.v20.i23.7223.
10
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis.NT pro BNP 血浆水平和心房容积与肝硬化的严重程度相关。
PLoS One. 2013 Aug 5;8(8):e68364. doi: 10.1371/journal.pone.0068364. Print 2013.

本文引用的文献

1
Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt.舒张功能障碍与经颈静脉肝内门体分流术的肝硬化患者生存率低相关。
Gut. 2007 Jun;56(6):869-75. doi: 10.1136/gut.2006.102467. Epub 2006 Nov 29.
2
Therapy insight: Cirrhotic cardiomyopathy.治疗洞察：肝硬化性心肌病。
Nat Clin Pract Gastroenterol Hepatol. 2006 Jun;3(6):329-37. doi: 10.1038/ncpgasthep0498.
3
Cardiac and vascular changes in cirrhosis: pathogenic mechanisms.肝硬化时的心脏和血管变化：发病机制
World J Gastroenterol. 2006 Feb 14;12(6):837-42. doi: 10.3748/wjg.v12.i6.837.
4
Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography.舒张性心力衰竭可通过二维和多普勒超声心动图综合检查来诊断。
J Am Coll Cardiol. 2006 Feb 7;47(3):500-6. doi: 10.1016/j.jacc.2005.09.032. Epub 2006 Jan 18.
5
Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.肝硬化患者生存的自然史及预后指标：118项研究的系统评价
J Hepatol. 2006 Jan;44(1):217-31. doi: 10.1016/j.jhep.2005.10.013. Epub 2005 Nov 9.
6
Transjugular intrahepatic portosystemic shunt for acute variceal bleeding in patients with viral liver cirrhosis: predictors of early mortality.经颈静脉肝内门体分流术治疗病毒性肝硬化患者急性静脉曲张出血：早期死亡率的预测因素
AJR Am J Roentgenol. 2005 Oct;185(4):885-9. doi: 10.2214/AJR.04.0607.
7
Circulatory function and hepatorenal syndrome in cirrhosis.肝硬化中的循环功能与肝肾综合征
Hepatology. 2005 Aug;42(2):439-47. doi: 10.1002/hep.20766.
8
Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.经颈静脉肝内门体分流术治疗顽固性腹水：一项荟萃分析。
Liver Int. 2005 Apr;25(2):349-56. doi: 10.1111/j.1478-3231.2005.01095.x.
9
Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.肝硬化患者心脏手术后的预后预测：Child-Pugh评分与终末期肝病模型（MELD）评分的比较
Clin Gastroenterol Hepatol. 2004 Aug;2(8):719-23. doi: 10.1016/s1542-3565(04)00296-4.
10
Humoral and cardiac effects of TIPS in cirrhotic patients with different "effective" blood volume.经颈静脉肝内门体分流术（TIPS）对不同“有效”血容量的肝硬化患者的体液和心脏影响。
Hepatology. 2003 Dec;38(6):1370-7. doi: 10.1016/j.hep.2003.09.030.

肝硬化患者生存的心血管决定因素

Cardiovascular determinants of survival in cirrhosis.

作者信息

Lee Samuel S, Liu Hongqun

机构信息

Liver Unit, University of Calgary, Calgary, Canada.

出版信息

Gut. 2007 Jun;56(6):746-8. doi: 10.1136/gut.2006.112169.

DOI:10.1136/gut.2006.112169
PMID:17519479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1954880/
Abstract

Diastolic response as the strongest determinant of mortality after TIPS

摘要

舒张期反应作为经颈静脉肝内门体分流术后死亡率的最强决定因素